Heron Therapeutics (HRTX) News Today → Central Bank Gold Heist In Progress (From Colonial Metals) (Ad) Free HRTX Stock Alerts $2.96 -0.10 (-3.27%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHRTX Apr 2024 1.500 callca.finance.yahoo.com - March 16 at 4:59 AMHeron Therapeutics Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - March 14 at 9:02 AMHeron Therapeutics (NASDAQ:HRTX) Price Target Increased to $5.00 by Analysts at Needham & Company LLCamericanbankingnews.com - March 14 at 3:10 AMHeron Therapeutics Soars After 4Q Earnings Beatmarketwatch.com - March 14 at 12:50 AMBiotech Finds Mid-Week Success Following Q4 Earnings Releasetheglobeandmail.com - March 13 at 7:49 PMWhy Is Postoperative Pain Focused Heron Therapeutics Stock Trading Higher On Wednesday?markets.businessinsider.com - March 13 at 7:49 PMQ4 2023 Heron Therapeutics Inc Earnings Callfinance.yahoo.com - March 13 at 9:49 AMHeron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 13 at 9:49 AMHeron Therapeutics (NASDAQ:HRTX) Given New $5.00 Price Target at Needham & Company LLCmarketbeat.com - March 13 at 8:18 AMHeron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updatesfinance.yahoo.com - March 12 at 6:03 PMHeron Therapeutics Inc (HRTX) Exceeds Full-Year Revenue Guidance for 2023finance.yahoo.com - March 12 at 6:03 PMHeron Therapeutics, Inc. (NASDAQ:HRTX) Shares Acquired by Adage Capital Partners GP L.L.C.marketbeat.com - March 12 at 5:53 AMHeron Therapeutics Q4 2023 Earnings Previewmsn.com - March 11 at 8:11 PMWhat Wall Street expects from Heron Therapeutics's earningsmarkets.businessinsider.com - March 11 at 3:10 PMPreview: Heron Therapeutics's Earningsbenzinga.com - March 11 at 3:10 PMHeron Therapeutics (HRTX) to Release Quarterly Earnings on Tuesdaymarketbeat.com - March 5 at 4:50 AMHeron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024finance.yahoo.com - February 28 at 10:49 AMHeron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024prnewswire.com - February 28 at 8:00 AMHeron Therapeutics (HRTX) Price Target Increased by 18.52% to 6.80msn.com - February 24 at 9:19 AMHeron Therapeutics Stock (NASDAQ:HRTX), Short Interest Reportbenzinga.com - February 22 at 9:16 AMHeron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by D.A. Davidson & CO.marketbeat.com - February 17 at 6:12 AMHRTX Mar 2024 0.500 callfinance.yahoo.com - February 17 at 1:37 AMTejara Capital Ltd Acquires 469,548 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)marketbeat.com - February 16 at 12:21 PMInvestors in Heron Therapeutics (NASDAQ:HRTX) from five years ago are still down 90%, even after 23% gain this past weekfinance.yahoo.com - February 16 at 10:36 AMJW Asset Management LLC Increases Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX)marketbeat.com - February 12 at 12:53 PMOcular Therapeutix (OCUL) Surges 12.9%: Is This an Indication of Further Gains?finance.yahoo.com - February 12 at 8:20 AMAll You Need to Know About Heron Therapeutics (HRTX) Rating Upgrade to Strong Buyfinance.yahoo.com - February 6 at 1:46 PMHeron (HRTX) Gains 19% on FDA Nod for Zynrelef Label Expansionfinance.yahoo.com - January 25 at 8:39 AMHeron Therapeutics Shares Rise 15% After FDA Approves Expanded Use of Zynrelefmarketwatch.com - January 24 at 10:38 PMHeron Therapeutics: Strong Buy on Zynrelef’s Market Expansion and Strategic Collaborationsmarkets.businessinsider.com - January 24 at 10:38 PMPremarket Heats Up For Biotech Before Opening Bellmsn.com - January 24 at 5:34 PMHeron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nodfinance.yahoo.com - January 24 at 5:34 PMHeron Therapeutics rises on securing label expansion for pain therapymsn.com - January 24 at 7:44 AMHeron : FDA Oks ZYNRELEF Indication Expansion To Include Addl. Orthopedic & Soft Tissue Proceduresmarkets.businessinsider.com - January 24 at 2:43 AMHeron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Proceduresfinance.yahoo.com - January 23 at 9:42 PMHeron Therapeutics, Inc. (NASDAQ:HRTX) is largely controlled by institutional shareholders who own 52% of the companyfinance.yahoo.com - January 22 at 9:57 AMHeron Therapeutics (HRTX) Just Flashed Golden Cross Signal: Do You Buy?finance.yahoo.com - January 15 at 12:53 PMHeron Therapeutics Shares Rise 17% After Zynrelef Distribution Partnershipmarketwatch.com - January 9 at 6:38 PMStockNews.com Downgrades Heron Therapeutics (NASDAQ:HRTX) to Sellmarketbeat.com - January 8 at 10:18 PMTraders Buy High Volume of Heron Therapeutics Call Options (NASDAQ:HRTX)marketbeat.com - January 8 at 11:23 AMHeron gains on deal to expand sales network for pain therapy Zynrelefmsn.com - January 8 at 9:52 AMHeron Therapeutics Partners With CrossLink Life Sciences To Expand Promotional Effort For Zynrelefmarkets.businessinsider.com - January 7 at 11:09 PMHeron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Painfinance.yahoo.com - January 7 at 6:08 PMHeron Therapeutics Gets Back On Trackseekingalpha.com - December 29 at 6:09 PMHeron Therapeutics Stock (NASDAQ:HRTX) Dividends: History, Yield and Datesbenzinga.com - December 22 at 1:54 PMWhy Heron Therapeutics Is A Compelling Buy Into 2024seekingalpha.com - November 30 at 10:38 PMCEO & Director of Heron Therapeutics Craig Collard Buys 411% More Sharesfinance.yahoo.com - November 19 at 7:39 AMHeron Therapeutics, Inc.: Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidancefinanznachrichten.de - November 17 at 6:54 PMAnalysts Offer Insights on Healthcare Companies: Asensus Surgical (ASXC), Cue Health (HLTH) and Heron Therapeutics (HRTX)markets.businessinsider.com - November 15 at 10:27 PMWhy Is Pain Treatment Focused Heron Therapeutics Stock Trading Higher Today?markets.businessinsider.com - November 15 at 5:27 PM Get Heron Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address AI Cracks Open Largest Untapped Energy Reserve on Earth (Ad)This orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit HRTX Media Mentions By Week HRTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HRTX News Sentiment▼0.650.63▲Average Medical News Sentiment HRTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HRTX Articles This Week▼152▲HRTX Articles Average Week Get Heron Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Inozyme Pharma News Today Amarin News Today Neoleukin Therapeutics News Today Harrow Health News Today Atea Pharmaceuticals News Today Alto Neuroscience News Today Dianthus Therapeutics News Today Aquestive Therapeutics News Today Precigen News Today Kamada News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HRTX) was last updated on 3/19/2024 by MarketBeat.com Staff From Our Partners8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & CompanyStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.